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Background: The switch from cartilage template to bone during endochondral ossification of the growth plate
requires a dynamic and close interaction between cartilage and the developing vasculature. Vascular invasion of the
primarily avascular hypertrophic chondrocyte zone brings chondroclasts, osteoblast- and endothelial precursor cells
into future centres of ossification.
Vascularization of human growth plates of polydactylic digits was studied by immunohistochemistry,
confocal-laser-scanning-microscopy and RT-qPCR using markers specific for endothelial cells CD34 and CD31,
smooth muscle cells α-SMA, endothelial progenitor cells CD133, CXCR4, VEGFR-2 and mesenchymal progenitor cells
CD90 and CD105. In addition, morphometric analysis was performed to quantify RUNX2+ and DLX5+ hypertrophic
chondrocytes, RANK+ chondro- and osteoclasts, and CD133+ progenitors in different zones of the growth plate.
Results: New vessels in ossification centres were formed by sprouting of CD34+ endothelial cells that did not co-express
the mature endothelial cell marker CD31. These immature vessels in the growth plate showed no abluminal coverage
with α-SMA+ smooth muscle cells, but in their close proximity single CD133+ precursor cells were found that did
not express VEGFR-2, a marker for endothelial lineage commitment. In periosteum and in the perichondrial groove
of Ranvier that harboured CD90+/CD105+ chondro-progenitors, in contrast, mature vessels were found stabilized by
α-SMA+ smooth muscle cells.
Conclusion: Vascularization of ossification centres of the growth plate was mediated by sprouting of capillaries coming
from the bone collar or by intussusception rather than by de-novo vessel formation involving endothelial progenitor
cells. Vascular invasion of the joint anlage was temporally delayed compared to the surrounding joint tissue.
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The growth plate primarily accounts for the longitudinal
growth of bone, and is anatomically subdivided into a
series of zones with unique morphological and biochem-
ical features [1-8]. The resting zone (RZ, germinal layer)
is formed by small, uniform, compactly located chondro-
cytes, rich in lipid and cytoplasmic vacuoles, that occur
individually or in pairs and are embedded in the extra-
cellular matrix (ECM). The RZ is characterized by low* Correspondence: michael.b.fischer@meduniwien.ac.at
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unless otherwise stated.rates of chondrocytes replication, proteoglycan and col-
lagen type IIB synthesis. In the proliferative zone (PZ)
chondrocyte are tightly bound in columns parallel to the
axis of the length of the bone where they can proliferate
and differentiate. The hypertrophic zone (HZ), with its
upper zone of maturation and the lower zone of degen-
eration, is the layer where blood vessels invade, along
with chondroclasts that degrade and remodel the cartil-
age extracellular matrix (ECM). In the zone of chon-
drocyte maturation, extracellular matrix consisting of
collagen type II, IX and XI, the proteoglycans aggrecan,
decorin and biglycan and other non-collagenous proteins
such as cartilage oligomeric protein (COMP), which
allow the recently divided chondrocytes to separate from
each other. Osteoblast precursor cells that adhere to the
remnants of the cartilage ECM, form bone tissue inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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calcification zone (CZ). The progression of chondrocytes
from the resting over the proliferating to the hyper-
trophic state of differentiation that culminates in matrix
vesicle calcification happens within hours and is an ac-
tive process that ends with apoptosis and/or autophagic
cell death [7]. An encircling fibrochondrosseous struc-
ture surrounding the growth plate called the perichon-
drial groove of Ranvier (GOR) and the ring of LaCroix
(ROL), harbours pre-chondrocytes with a high prolifera-
tive capacity responsible for the circumferential growth
of cartilage and a developed vascularisation [8-11].
Vascular invasion of the primarily avascular hyper-
trophic chondrocyte zone of the growth plate is a pre-
requisite for the process of endochondral bone formation
and occurs in a sequence of events [12-15]. There is no
evidence of in vivo one step trans-differentiation of chon-
drocytes to osteocytes. This switch requires a dynamic and
close interaction between the cartilage and vascular struc-
tures, involving two types of molecules in this process:
proteases and growth factors such as metalloproteinase
9 (MMP9), gelatinase B (GelB), vascular endothelial
growth factor (VEGF), fibroblast growth factor 18 (FGF18)
[13,16-18]. Endothelial cells coming from the bone collar
invade the terminal layer of apoptotic chondrocytes to
form vascular channels [19]. These newly formed blood
vessels provide access for several highly specialized pro-
genitor cells involved in the initiation and regulation of
osteogenesis, such as chondroclasts-, osteoblast-, and
osteoclast-progenitors, as well as endothelial- and pericyte
(smooth muscle) progenitor cells inducing vasculogenesis
[13,14,19]. Collectively, chondroclasts that differentiate
from chrondroclast-precursors degrade and remodel
the cartilage extracellular matrix (ECM), so osteoblast
precursor cells can adhere to the remnants of the car-
tilage ECM, differentiate to osteoblasts and form bone
tissue in primary ossification centres [20]. The ECM
deposited by RUNX2/3 driven hypertrophic chondro-
cytes serves as a template for subsequent bone formation
and these cells can also secrete proteins such as receptor
activator of NF-κB ligand (RANKL), Indian hedgehog
(Ihh) and VEGF that control the activity of osteoblast-,
osteoclast- and endothelial precursor cells coming in
from the circulation during the process of endochondral
ossification [16-18,21-26].
In order to investigate new vessel formation in primary-
(POCs) and secondary ossification centres (SOCs) of the
developing human growth plate, immunohistochemistry,
confocal laser scanning microscopy and RT-qPCR were
used with markers expressed on endothelial cells (CD34
and CD31), on hematopoietic precursor cells (CD133 and
CXCR4), on smooth muscle cells (α-SMA), and on mesen-
chymal precursor cells (CD90 and CD105) [8-11,27]. In
addition, morphometric analysis was applied to quantifythe occurrence of the respective cells in the growth plate
and in the surrounding perichondrial area.
Results
Terminally differentiated chondrocytes express transcription
factors RUNX2 and DLX5 and chondroclasts express RANK
in newly formed ossification centres
Of the 23 patients included in this study, digits of 15
patients had well developed growth plates with primary
and secondary ossification centres (Table 1, Figures 1
and 2) while the remaining eight showed developing as
well as undeveloped growth plates with cartilage anlagen
(Table 1). We found hypertrophic chondrocytes located
in the PZ that started to express the transcription factors
RUNX2 and DLX5 in digits with active endochondral
ossification of the growth plate (Figure 1B,C). A maximum
of RUNX2 and DLX5 expression was found in terminally
differentiated chondrocytes of the HZ (Figure 1B,C).
Layers of multiple hypertrophic chondrocytes located in
the PZ and certain terminally differentiated chondrocytes
of the HZ also expressed RANKL in a developmental
stage before they underwent apoptosis and/or autophagic
cell death (Figure 1E). In POCs and SOCs that assembled
the provisional CZ, multinucleated chondroclasts express-
ing RANK on their surface showed ruffled border forma-
tion to degrade and resorb the cartilage matrix, while the
osteoblasts in newly formed bone expressed OPG and
RANKL (Figure 1D,E,F). The remaining eight fingers,
where the growth plate had not yet fully developed,
presented either an intact cartilage anlage or showed initi-
ation of a primary centre of ossification in the middle
of the cartilage model. These newly formed ossification
centres harboured hypertrophic chondrocytes expressing
RUNX2, DLX5 and RANKL, multinucleated osteoclasts
with ruffled border formation along the lacunae express-
ing RANK on their surface and osteoblast expressing
RANKL and OPG according to the extent of endochon-
dral ossification (data not shown).
New vessel formation in primary and secondary ossification
centres is mediated by sprouting rather than by de-novo
vessel formation
In POCs and SOCs of the provisional CZ, CD34+ endo-
thelial cells were shown to form vascular arcades and
immature capillaries that had not yet been stabilized by
α-SMA bearing subendothelial smooth muscle cells
(Figure 2A). Precursor cells from the mesenchymal lineage
expressing CD90 and CD105 co-localize with CD34+
immature endothelial cells of the newly formed sprouts
(Figure 2A,D,E). Only a coordinated and finely tuned
concurrent development of immature CD34+ endothelial
cells and subendothelial CD90+/CD105+ smooth muscle
cell precursors is a prerequisite for successful new vessel
formation. In close proximity to these immature vessels,
Table 1 Description of the different developing stages of growth plate samples
Patient Sex Age range Stage of development
F: female; M: male months at date of surgery Developing stage Endochondral ossification GOR ROL
1 F 12 +++ ++ +++ +++
2 F 11 ++ + +++ +++
3 F 11 +++ +++ +++ +++
4 F 54 + o o o
5 M 54 +++ +++ +++ +++
6 F 26 + + o o
7 F 11 +++ +++ +++ +++
8 M 18 ++ o o o
9 M 11 ++ o o o
10 M 26 +++ +++ +++ +++
11 M 6 ++ + +++ o
12 M 11 +++ +++ +++ +++
13 M 16 +++ +++ +++ +++
14 M 41 ++ ++ + +++
15 F 105 +++ +++ +++ +
16 F 13 ++ ++ +++ +++
17 M 33 +++ +++ +++ +++
18 F 7 +++ ++ +++ +++
19 M 11 +++ ++ +++ +++
20 F 25 +++ +++ +++ +++
21 M 45 +++ +++ +++ +++
22 F 46 +++ ++ +++ +++
23 M 7 +++ ++ +++ +++
o not developed; + beginning to develop; ++ developing; +++ developed.
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but not in SOCs (Figure 2C). These very rarely occurring
cells are most likely bone marrow derived and enter the
POCs from the circulation during the process of vascular
invasion. They were shown to express the chemokine
receptor CXCR4 (Figure 2F), the receptor for CXCL12
(SDF-1) involved in selective home of precursor cells to
sites of new vessel formation [28]. In accordance with
previous studies CXCR4 is widely expressed on precursor
cells of the endothelial lineage, osteoblasts, RANKL acti-
vated osteoclasts and activated lymphocytes [29,30]. In
addition to their appearance in the POCs, CD133+ precur-
sor cells could be found on the surface of the articular
cartilage where they formed a thin layer of cells, as well as
in the perichondrium and periosteum (data not shown).
Of the two receptors binding to the different isoforms of
VEGF, VEGFR1 was found to be expressed by mature
endothelial cells in vessels of newly formed bone and
VEGFR2 on immature endothelial cells in vascular arcades
and developing vessels within POCs (Figure 2G,H). We
found no evidence of VEGFR2+ expression on CD133+endothelial precursor cells in newly formed vessels within
POCs. This rare population of CD133+VEGFR2+ endo-
thelial precursors were shown to represent less than 2%
of stem cells in the circulation and had a high potential
to differentiate along the endothelial lineage ex vivo
[31,32]. During their maturation to endothelial cells,
they lose CD133 and gain CD31 and vWF [33].
Angiogenesis with sprouting of new capillaries from
pre-existing vessels and intussusception, with division
of one vessel into two by the formation of a new vessel
wall in the lumen of the original vessel, is more likely
responsible for new vessel formation than vasculogen-
esis mediated by CD133+VEGFR2+ endothelial precur-
sors [33]. In the newly formed bone, in contrast, the
majority of CD34+ endothelial cells were also CD31+
and vessels were covered with α-SMA+ smooth muscle
cells (Figure 2B), indicating that these vessels were
mature and stabilized (Figure 1G, Figure 2B and see for
more detail Figure 3K,L). Digits where the removal of
embryonic cartilage by endochondral ossification had
not yet been initiated showed no occurrence of CD133+
Figure 1 RUNX-2, DLX-5, OPG, RANKL, RANK and CD31 expression in growth plate (n = 23). Longitudinal sections of the three investigated
histological zones defined as calcification zone (CZ), hypertrophic zone (HZ) and proliferating zone (PZ) were stained with hematoxilin and eosin (HE)
(A) and Immunhistochemical staining with specific mABs for RUNX-2 (B), DLX-5 (C), OPG (D), RANKL (E), RANK (F) were shown in one representative
sample including one representative isotype control (H). Large arrowheads indicate the area of the insert (scale bar equals 50 μm), small arrowheads
indicate specific cells. Hypertrophic chondrocytes expressed RUNX-2 (B) and DLX-5 (C). Multinucleated RANK+ chondroclasts with brush borders were
found in the CZ (F), and vessels in newly formed bone but not in POCs expressed CD31 the marker for mature endothelial cells (G).
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Figure 2 CD34, α-SMA, CD133, CD90, CD105, CXCR4, VEGFR1, VEGFR2 expression in growth plate and in the surrounding GOR (n = 23).
An entire digit section was scanned by TissueFAXS (overview) including uncalcified cartilage (C), area of ongoing calcification (*), joint cavity (JC),
surrounding soft tissue (ST), articular cartilage (AC), Groove of Ranvier (GOR), POC, and SOC. Immature endothelial cells in POCs expressed CD34
(A), abluminal coverage with α-SMA+ smooth muscle cells was found on vessels in newly formed bone but not in POCs and SOCs (B). Single
CD133 precursor cells were found in POCs in close proximity to newly formed vessels (C), mesenchymal progenitor cells expressing CD90 (D) and
CD105 (E) co-localized with CD34+ endothelial cells in POCs. CXCR4+ cells (F) could be localized in POCs. VEGFR1 (G) is expressed on endothelial
cells of vessels in newly formed bone, while VEGFR2 (H) is expressed on immature CD34+ endothelial cells in POCs. The groove of Ranvier
(GOR) (J) showed intense vascularisation (K) with mesenchymal progenitors expressing CD105 (L). A representative isotype control was included
(I). Large arrowheads indicate the area of the insert (scale bar equals 50 μm), small arrowheads indicate specific cells.
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Figure 3 A-E: Spouting of new vessels in primary ossification centres of the growth plate. CD34+ (green) endothelial cells formed cascades
that had not been stabilized by α-SMA bearing sub-endothelial smooth muscle cells (blue) in immature vessel formations. F-J: Vasculature in the
surrounding articular soft tissue showed continuous lining of CD34+ (green) endothelial cells partly sharing (yellow) endothelial CD31+ (red)
presence in already α-SMA bearing sub- endothelial smooth muscle cells (blue) stabilized mature vessels. K-L: Mature vessels with a lumen and
CD34+ (green) and CD31+ (red) endothelial cells as well as α-SMA bearing smooth muscle cells (blue) A-L were displayed in confocal Laser
Scanning Microscopy (630x magnification), all cellular nuclei were counterstained with DAPI (white). To enable comparison across the panel of
CD34, CD31 and α-SMA, parameters for data acquisition were kept constant.
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vessel formation during the process of vascular invasion
of the cartilage starting from the periosteal bone collar
is mediated by sprouting (data not shown).
Vascularisation of the groove of ranvier and the ring
of LaCroix
Within the perichondrial GOR and ROL we found stabi-
lized vessels with CD34+ endothelial cells and abluminal
coverage with α-SMA+ smooth muscle cells but no evi-
dence for CD133+ precursor cells (Figure 2K). The ma-
jority of cells resident in the GOR were of mesenchymal
origin because they expressed markers for mesenchymal
progenitor cells such as CD90 (data not shown) and CD105
(Figure 2L) and lacked CD45 excluding their myeloidorigin. The perichondrium and periosteum surrounding the
growth plate were highly vascularized with stabilized vessels
and capillaries and harboured CD133+ progenitor cells
(data not shown). Digits with only one cartilage anlage or
those at the beginning of central ossification within the
cartilage anlage showed no GOR and ROL comparable to
that observed in growth plates (data not shown).
Morphometric analysis of precursor cells in different
areas of the growth plate
Quantitative histomorphometric measurements giving
the numbers of positive precursor cells, hypertrophic chon-
drocytes and mature endothelial cells found per mm2 in
the different zones of the growth plate and are depicted in
Figure 4.
Figure 4 Morphometric analysis: Number of CD34, CD45, CD133, CXCR4, RANK, RANKL, OPG, RUNX-2 and DLX-5 positive cells/mm2 in
the resting zone (RZ), proliferating zone (PZ), hypertrophic zone (HZ) and calcification zone (CZ) of the growth plate were counted in
10 fields of 1 mm2 (n = 12). Statistically significant differences are indicated as *p < 0.05, **p < 0.005, ***p < 0.001.
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Laser confocal microscopy was used to further characterize
sprouting of new vessels in primary ossification centres of
the growth plate in polydactylic fingers. In ossification cen-
tres of the provisional CZ, CD34+ endothelial cells (green)
were shown to form vascular arcades as well as im-
mature capillaries that had not yet been stabilized by
α-SMA bearing sub-endothelial smooth muscle cells (blue)
(Figure 3A-E). Vascular development within the soft tissue
surrounding the growth plate seemed to have proceeded
much further than within the provisional CZ of the growth
plate. The vasculature within the soft tissue of the joint
showed continuous lining of endothelial cells stained with
CD34 (green) and partial staining of these endothelial cells
with CD31 (red) (Figure 3F-J). Furthermore, stabilization
with α-SMA bearing sub-endothelial smooth muscle cells
(blue) already occurred, indicating stable mature vessels.
The endothelial lining in provisional CZ of the growth
plate, in contrast, showed no signs of continuity asdepicted by CD34 staining of endothelial cells (green).
Several CD34+ endothelial cell clusters of 2–4 cells were
observed separated from each other with no tendency to
connect for alignment. In addition, few CD31+ mature
endothelial cells (red) were found in provisional CZ and
no signs of stabilization of vessels with α-SMA bearing
sub-endothelial smooth muscle cells (blue) indicating that
these newly formed vessels were immature.
RT-qPCR of CD34, CD31 and CD133 expression in cultured
adherent cells of the growth plate
Cultured adherent cells of the dissected growth plate
were investigated for their expression of CD34, CD31
and CD133 message by RT-qPCR in order to estimate
activity of new vessel formation [34]. With respect to
GAPDH arbitrarily set at 1,000, the mRNA levels of
CD34, CD31, and CD133 were ranging from 0.02 to 0.7,
0.001 to 0.4, and, 0.002 to 0.1, respectively, across all
eight independent samples (Figure 5). In comparison,
Figure 5 mRNA levels of CD 34, CD31 and CD133 were
quantified (n = 8) using RT-qPCR and expressed as numbers of
molecules by 1,000 molecules of GAPDH (NMby1000GAPDH).
Adherent cells isolated from dissected growth plates were cultured
and analyzed separately. Results are given as mean values with
standard deviation.
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mRNA in each patient-derived cell population, barely
missing the level of significance (p = 0.07).
Discussion
During the process of endochondral bone formation that
leads to the establishment of the diaphyseal POCs
and epiphyseal SOCs, a coordinated transition from
proliferation to terminal differentiation and hypertrophy
of chondrocytes occurs that ends with hypertrophic
chondrocytes mineralising their ECM and undergoing
apoptosis or autophagic cell death [2,4,7]. Endothelial
cell invasion starts with the generation of vascularized
cartilage canals from the perichondrium into the ter-
minal layer of apoptotic chondrocytes ending with the
formation of new capillaries in POCs [19]. In ossification
centres, the vascularization was shown to occur prior to
hypertrophy, matrix mineralization and subsequent apop-
tosis or autophagic cell death of chondrocytes [19]. To
create a suitable environment for vascular invasion, we
found coordinated transition from proliferation to ter-
minal differentiation and hypertrophy of chondrocytes,
tightly regulated under the control of transcription factors
RUNX2 and DLX5, in human growth plates investigated.
Newly formed blood vessels provide access for a myriad of
different precursor cells with high specialization involved
in the development of ossification centres [9-11,35]. We
found evidence for the appearance of CD90+ progenitor
cells of the mesenchymal lineage in POC and SOC, but
progenitor cells of the myeloid lineage expressing CD133
were extremely rare. In POCs but not in in SOCs, single
CD133+ progenitor cells could be detected next to imma-
ture vessels and vascular arcades with a lining of CD34+
endothelial cells. Interestingly, CD90+ precursor cells
from the mesenchymal lineage tend to seek physicalcontact to CD34+ immature endothelial cells of the
newly formed endothelial sprouts. These immature
vessels lacked abluminal coverage with α-SMA+ smooth
muscle cells that are important for vessel stabilization
because they prevent vessel pruning [36]. It seems likely
that only a coordinated and finely tuned concurrent
development of immature CD34+ endothelial cells and
subendothelial CD90+ smooth muscle cell precursors is a
prerequisite for successful new vessel formation in POCs
as well as SOCs. Subendothelial smooth muscle cells can
develop from pericytes. These cells can be recruited from
neighbouring resident mesenchymal cells through repli-
cation, migration and differentiation of other pericytes of
the growing vascular bud or they can arise from mesen-
chymal progenitors [35,37]. There is a physiological need
for cross-differentiation of connective tissue cells in
neovascularization, namely the need to adapt different
tissues that reside next to one another during the process
of vessel stabilization [37]. Although extensively investi-
gated, we found no evidence for the occurrence of endo-
thelial progenitor cells expressing CD133 and VEGFR-2
in POCs and SOCs. It seems likely that new vessels were
formed by the sprouting of new capillaries from the
pre-existing vessels coming from the bone collar or by
intussusception rather than by de-novo vessel formation
by endothelial progenitor cells expressing CD133 and
VEGFR-2. Recently it was shown that endochondral
ossification is required for haematopoietic stem-cell
niche formation [36]. Matrigel embedded progenitor cells
with surface markers CD105+Thy1− (CD90) sorted from
15.5 days post-coitum fetal bones could recruit, when
transplanted under the adult mouse kidney capsule,
host-derived blood vessels, produce donor derived ec-
topic bone through a cartilage intermediate and gener-
ate a marrow cavity populated by host-derived long-
term reconstituting HSCs [36]. These results might sup-
port our hypothesis that the CD133+ progenitor cells found
in POCs and SOCs of polydactylic digits are involved in
the formation of future stem-cell niches rather than in
vasculogenesis.
Vascularization in GOR and ROL, that serve as a
reservoir for pre-cartilaginous cells in the germ layer
[38] and in case of ROL keeps the cells from oozing out
under axial loading, was found to be more developed
than in the corresponding ossification centres. An intact
perichondrial zone with optimal vascularization is im-
portant for longitudinal bone growth, as Salter-Harris
type IV fractures within the GOR led to severe growth
disturbances [39,40]. Small capillaries with CD34+ endo-
thelial cells stabilized with α-SMA+ smooth muscle cells
were found from the onset of GOR and ROL. The GOR
was shown to maintain their progenitor properties very
similar to bone marrow stem cell niches and harbours
an extensive vascular network [9,10]. Precursor cells
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white rabbits expressed STRO-1, Jagged1 and bone
morphogenetic protein receptor 1a (BMPr1a) and had
a morphology similar to mesenchymal stem cells. We
found progenitor cells of the mesenchymal lineage
expressing CD90 and to a certain extent CD105 in the
basal layer of the GOR according to previous reports
[9-11,35]. When these mesenchymal progenitor cells
differentiate, they lose expression of CD90 and CD105
and move to the apical part of the GOR to be dispersed
later throughout the cartilage. In a mouse model, these
extensive proliferating cells were shown to incorporate
BrdU into their DNA after 10–12 days of BrdU feeding,
and transfected cells from the GOR initially migrated
back to the perichondrial groove and later deeper into
the epiphysis [41] or to the surface of the articular
cartilage [9]. In addition, the perichondrium and perios-
teum, adjacent to the physis, was found to be highly
vascularized and harboured multiple single CD133+
progenitor cells.
Eight of the immature growth plates investigated
showed either a cartilage anlage or the beginning of
central ossification. The cartilage anlage that forms as a
result of mesenchymal condensation and subsequent dif-
ferentiation into cartilage, is a primary avascular struc-
ture, which relies on receiving oxygen and nutrients via
diffusion [42]. In this stage of growth plate development,
oxygen debt due to a lack of blood vessels was shown to
increase the anabolic metabolism of growth plate chon-
drocytes and up-regulated hypoxia-inducible factors
(HIFs) [11,43]. HIF-1α is necessary for chondrocyte sur-
vival during hypoxia, stimulates production of collagen
type II, and induces the expression of different VEGF
isoforms in chondrocytes. VEGF is first present in the
cartilaginous ECM and, upon degradation of this ECM
by MMPs like MMP-2, MMP-9 and MMP13, VEGF is
released and can bind to VEGFR1 and 2 on vascular
endothelial cells, and pre-osteoblasts, thereby favouring
vascular invasion and cartilage replacement by bone
[44]. In this stage of bone development we found no
evidence for VEGFR1 or VEGFR2 expressing endothelial
cells or endothelial progenitor cells.
Conclusions
In conclusion we can say that new vessel formation in
the human growth plate is mediated by sprouting of
capillaries coming in from the bone collar rather than by
de novo vessel formation mediated by endothelial pre-
cursor cells. Understanding the complex physiology of
growth plate development, where a single cell type, the
chondrocyte, can render the impulse for the growth of
massive bone from embryonic life to adulthood, supported
by the growing vascular network, will help to establish new
strategies in personalized regenerative medicine.Methods
Patients
Digits of 23 infants (11 females, 12 males) with bilateral
polydactyly were collected after surgical removal of the
digits between 6 and 105 months after birth. The pa-
tients’ tissues were included in the study with informed
consent of the parents. The study was performed according
to the guidelines of the Medical University of Vienna [45]
and the study was approved by the Ethics Commitee of the
Medical University Vienna (EK Nr.: 1830/2012).
Immunohistochemistry and immune-morphometric analysis
The resected polydactylic digits were fixed in 10% formalin
for 3 days and then embedded in paraffin after decalcifi-
cation as described before [45]. After de-paraffination
through xylene and graded alcohol, the specimens were
cut into slices of approximately 4–6 μm. For removal of
endogenous peroxidase the material was treated with 3%
H2O2, followed by antigen retrieval in the microwave
(10 min, 150 W) in citrate buffer (pH = 6.0) as previously
described [45]. Sections of paraffin embedded tissues were
treated with horse serum (CD133, CD34, CD45, CXCR4,
RANK and OPG) or goat serum albumin (RANKL, DLX5,
RUNX2) for 30 min at room temperature and subse-
quently incubated with the primary antibodies against
CD133 (2.5 μg/ml mouse monoclonal antibody (mAb),
Miltenyi Biotec, Bergisch Gladbach, Germany; 1.3 μg/ml
goat polyclonal antibody (pAb), Santa Cruz Biotechnology,
Santa Cruz, CA), CD34 (2.5 μg/ml mouse mAb, Becton
Dickinson, San Jose, CA, or 0.5 μg/ml mouse mAb,
Immunotech, Marseilles, France), CXCR4 (2.5 μg/ml mouse
mAb, PharMingen, San Diego, CA), VEGFR-2 (2.5 μg/ml
mouse mAb, Santa Cruz Biotechnology, Cell Signalling
Technology, Danvers, MA), CD45 (3.5 μg/ml mouse mAb,
Becton Dickinson), CD90 (2 μg/ml mouse mAb, Novus
Biologicals, LLC, Littleton, CO), CD105 (2 μg/ml mouse
mAb, Labvision/Neomarkers, Freemont, CA), RANKL
(2 μg/ml rabbit mAb, Santa Cruz Biotechnology),
RANK (2 μg/ml goat pAb, Santa Cruz Biotechnology),
RUNX2 (2 μg/ml rabbit mAb, Oncogene, Cambridge, MA),
DLX5 (2 μg/ml rabbit mAb, Chemicon, Billerica, MA),
and OPG (2 μg/ml mouse mAb, R&D, Minneapolis, MN)
at 4°C overnight. Sections were washed thereafter 3 times
in PBS and the reactivity of the primary antibodies was
revealed using biotinylated anti-goat IgG (10 μg/ml,
Vector Laboratories, Burlingame, CA) for CD133 and
RANK, a biotinylated anti-mouse IgG (10 μg/ml, Vector
Laboratories) for CD34, CD133, CD45, OPG, VEGFR-2,
CD90, CD105, and CXCR4 and a biotinylated anti-rabbit
IgG (10 μg/ml, Vector Laboratories) for DLX5, RUNX2
and RANKL for 30 min at room temperature. The
unbound secondary antibody was removed by washing
three times in PBS, and visualization of antibody staining
was achieved using Vectastain ABC (Vector Laboratories,
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Isotype controls were included in the protocol (Figures 1H
and 2E). Entire digit sections (n = 3) stained by HE were
scanned with a Zeiss Observer. Z1 microscope equipped
with TissueFAXS and images were analyzed by HistoQuest
software (both from Tissue Gnostics GmbH, Vienna,
Austria). Morphometric analyses were performed by
counting the number of CD45, CD34, CD133, RUNX2,
DLX5, OPG, CXCR4, RANK, or RANKL positive cells in
10 fields of 1 mm2, selected at random as described earlier
by two independent investigators [27].Immunofluorescence and confocal laser microscopy
For immunofluorescence, paraffin embedded 2–3 μm
tissue sections (n = 10) were deparaffinized and blocked
with 10% donkey serum (Jackson Immunotech) for
30 min and subsequently incubated overnight at 4°C
with the mouse anti-CD31 (2.5 μg/ml, Dako) in 0.05 M
Tris Buffer. After washing the slides with TBS two times,
Alexa Fluor (AF) 555 conjugated donkey anti-mouse Ab
(2 μg/ml, Life Technologies Invitrogen) was applied
for one hour at room temperature (RT) followed by
blocking the sections with 20% mouse serum (Jackson
Immuno Research Laboratories, West Grove, PA, USA)
for 30 min at RT. Sections were blocked with affinity
purified Fab fragment donkey anti-mouse IgG (50 μg/ml,
Jackson) in TBS/5% donkey for 1 h at RT and with 10%
donkey serum (Jackson) for 30 min. to prevent cross
reaction. Thereafter, slides were incubated with an AF 488
conjugated CD 34 mAb (2.5 μg/ml, Becton Dickinson, NJ,
USA) overnight at 4°C. Repeat blocking of the sections
with 20% mouse serum (Jackson Immuno Research
Laboratories, West Grove, PA, USA), washing and incu-
bated again with affinity purified Fab fragment donkey
anti-mouse IgG in TBS/5% donkey for 1 h at RT to
prevent secondary antibody cross reaction with the third
primary mouse monoclonal antibody applied. After
additional blocking with 10% donkey serum the slides
were incubated with an α-SMA mAb (2.5 μg/ml,
Sigma-Aldrich, MO, USA) at 4°C overnight and α-SMA
staining was visualized using a AF 647 donkey anti-mouse
Ab (2 μg/ml, Invitrogen, CA, USA). Nuclei were stained
with 1.5 μM 4′,6 – diamino-2-phenylindole (DAPI, Sigma-
Aldrich, MO, USA). Isotype controls were included in the
protocol (data not shown). Images were acquired with
Zeiss LSM 700 confocal laser microscope (63× objective,
ZEN black imaging software).Cell culture and RT-qPCR
Growth plates (n = 8) were separated under stereo-
microscopic control from surrounding soft tissue of the
joint. Growth plate cartilage was then manually minced
and the remaining soft tissue removed prior to enzymaticdigestion at 37°C for 10–18 hours under constant agita-
tion using 2 mg/ml of Collagenase B (Roche Diagnostics,
Austria) [11]. Cells were centrifuged at 1300 rpm for
7 min and washed twice with PBS and strained through
40 μm filters (Falcon). Collected cells were plated in
alpha-modified minimum essential medium (alpha-
MEM; Sigma- Aldrich) supplemented with 10% FBS, 2%
Penicillin-Streptomycine (GIBCO Invitrogen, CA, USA),
0.5% L-Glutamine (GIBCO Invitrogen, CA, USA), 0.2%
Amphotericine B (PAA Laboratory, Austria), in 6 well
plates in a humidified atmosphere with 5% CO2 at 37°C.
Medium was changed after 24 h in order to remove
non-adherent cells from the culture and thereafter
the medium was replaced every 3–4 days until cell density
reached 80-90% confluence. Total RNA was extracted from
cultured cells of the growth plate using NucleoSpin® RNA
(Machery-Nagel, Germany) following the manufacturer’s
instructions. Each sample was run on the Agilent 2100
Bioanalyzer Nano LabChip for quality control and quanti-
fication of total RNA prior to reverse transcription.
RNA integrity numbers were between 9.3 and 10. The
purified RNA (10 ng/μl) was reverse transcribed with
the High Capacity cDNA Reverse Transcription Kit
(Life Technologies, Grand Island, NY, USA) under the
following conditions: 25°C for 10 min, 37°C for 120 min
followed by 85°C for 5 min. The qPCR reactions were
performed on an Applied Biosystems StepOnePlusTM
PCR device using SYBR® Green PCR Master Mix (Life
Technologies, Grand Island, NY, USA), sequence spe-
cific primers for GAPDH, CD34, CD 31 and CD133 at
a concentration of 100nM and 1 μl cDNA (diluted 1:5)
under the following conditions: 95°C for 10 min
followed by 40 cycles of 15 s of denaturation at 95°C,
60 s of annealing (55°C) and 60 s of elongation at 72°C.
A melting curve analysis was performed after each run
to confirm product specificity. mRNA expression levels
were calculated as relative copy numbers considering
actual amplification efficiencies and with respect to
that of glyceraldehyde-3- phosphate dehydrogenase
(GAPDH) set at 1,000. Technically, the protocol delib-
erately followed the minimal guidelines for the design
and documentation of qPCR experiments (MIQE) as
recently outlined [34,46]. A qPCR checklist listing
all relevant information is provided to assess the tech-
nical adequacy of the used qPCR protocols (Additional
file 1).
Statistic analysis
Paired Student’s t test was used to evaluate differences
in the number of CD45, CD34, CD133, RUNX2, DLX5,
OPG, CXCR4, RANK, and RANKL positive cells/mm2
in the RZ, PZ, HZ and CZ using the SSPS 22.0 and
Graph Pad Prism 5 software. Differences were statisti-
cally significant when p < 0.05.
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